About PeptidePub

PeptidePub is an independent research reference covering weight loss peptides. We do not sell peptides or provide medical care. We may earn referral fees from some telehealth providers, but those relationships do not control our editorial coverage.

Who We Are

We're a small, independent team that got frustrated watching GLP-1 coverage oscillate between breathless hype and reflexive skepticism. We built PeptidePub to be the resource we wished existed: evidence-based, clearly sourced, and transparent about how it makes money.

Our Methodology

Every claim we make is grounded in peer-reviewed literature or primary clinical trial data. We cite our sources, acknowledge the limits of existing research, and clearly distinguish between established findings and emerging or preliminary evidence. We don't extrapolate beyond what the data supports.

What We Cover

We focus on weight loss peptides — primarily semaglutide, tirzepatide, and retatrutide — as well as the GLP-1 drug class more broadly. Our content includes in-depth compound guides, head-to-head comparisons, and coverage of new research and pricing developments.

Our Editorial Independence Pledge

We don't sell peptides, manufacture medications, or accept pharmaceutical sponsorships. Some pages include affiliate links to telehealth providers. If you click those links and sign up, PeptidePub may earn a commission at no extra cost to you. Affiliate compensation never determines our scientific coverage, clinical interpretation, or provider notes.

You can read more about how this works on our disclosure page.

Follow Us

We post research updates, new articles, and quick-take analysis on X (formerly Twitter). Follow @PeptidePub to stay current.

Medical Disclaimer

PeptidePub is for educational and informational purposes only. Nothing on this site constitutes medical advice. Always consult a qualified healthcare professional before making any health-related decisions.